<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ESMO Congress 2025 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/esmo-congress-2025/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 14 Oct 2025 14:40:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>ESMO Congress 2025 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ESMO 2025: Previewing the Highlights of the Upcoming Congress Program</title>
		<link>https://bioengineer.org/esmo-2025-previewing-the-highlights-of-the-upcoming-congress-program/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 14 Oct 2025 14:39:31 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[antibody-drug conjugates research]]></category>
		<category><![CDATA[biomarker-driven cancer therapy]]></category>
		<category><![CDATA[Cancer immunotherapy advancements]]></category>
		<category><![CDATA[ESMO Congress 2025]]></category>
		<category><![CDATA[precision oncology AI innovations]]></category>
		<guid isPermaLink="false">https://bioengineer.org/esmo-2025-previewing-the-highlights-of-the-upcoming-congress-program/</guid>

					<description><![CDATA[Lugano, Switzerland, 13 October 2025 – The upcoming ESMO Congress 2025, set to unfold from October 17 to 21 in Berlin, Germany, constitutes a landmark event that promises to reshape the horizons of oncology research and clinical practice. This congress gathers the world’s preeminent oncology experts, who will unveil groundbreaking data and participate in high-level [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">280586</post-id>	</item>
		<item>
		<title>Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025</title>
		<link>https://bioengineer.org/dana-farber-leads-phase-3-trials-for-breast-lung-and-bladder-cancer-unveiled-at-esmo-congress-2025/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 13 Oct 2025 12:23:41 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[AI in cancer research]]></category>
		<category><![CDATA[biomarker-driven oncology]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[ESMO Congress 2025]]></category>
		<category><![CDATA[Phase 3 clinical trials]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dana-farber-leads-phase-3-trials-for-breast-lung-and-bladder-cancer-unveiled-at-esmo-congress-2025/</guid>

					<description><![CDATA[Dana-Farber Cancer Institute’s groundbreaking research continues to shape the landscape of oncology as their experts present a series of pivotal studies at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin. With a spotlight on breast, lung, and bladder cancers, these studies underscore the institute’s commitment to advancing cancer care through innovative clinical [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">279951</post-id>	</item>
	</channel>
</rss>
